Company / R&D per Share
Sana Biotechnology, Inc. R&D per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.94
FY2024
5-year range
$0.94 / $10.22
FY2020-FY2024
Trend
-31.8%
vs FY2023
Sector context
#148 of 208
Health Care
What the data says
At $0.94, Sana Biotechnology, Inc.'s r&d per share ranks #148 of 208 in the Health Care sector. Declined from $1.52 to $0.94 over the past 2 years.
Based on SEC 10-K filings.
0.94 in FY2024 with a 5-year CAGR of -45.9%.
Declined from $1.52 to $0.94 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -14.2%
- 5-Year CAGR
- -45.9%
- 10-Year CAGR
- -
Sector benchmark
#148 of 208 in Health CareTop 71% of 208This company $0.94 Sector average $28.82
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 31.8% year-over-year.
- Ranks #148 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.94 | -31.8% |
| FY2023 | $1.38 | -9.0% |
| FY2022 | $1.52 | +1.6% |
| FY2021 | $1.49 | -85.4% |
| FY2020 | $10.22 | -49.7% |
| FY2019 | $20.31 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026